Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Acticin, acute, affiliated, Akzo, Apokyn, ApokynTM, arguing, assigned, AstraZeneca, Beneficial, Canadian, Caribe, carryforward, Commerce, Commonwealth, consecutive, counter, cream, defense, Delaware, deliver, disorder, disposition, EMSAM, EMSAMTM, enjoining, enrolled, Esteve, frozen, harbor, headcount, House, hydrochloride, hypomobility, improved, injection, intention, intermittent, invention, inventor, Issuer, joined, judge, KUDCo, maximize, Maxzide, mechanism, methodology, mg, MPI, nitrate, Nobel, notification, NYSE, omeprazole, Organon, overseeing, pertaining, Pharma, pharmacological, Phenytek, PLC, prejudice, proceed, prohibit, purpose, Quimica, restricted, Schwarz, sertaconazole, size, slight, therapy, unearned, unlawful, unsettled, upcoming, Urban
Removed:
achieving, acne, American, anticipate, applicability, assist, auditing, beginning, Carolina, consultant, cover, credited, declaratory, depression, division, Eastern, escrow, expiring, Florida, FTC, meeting, nonpublic, North, Park, Pharm, Prepaid, prescribed, registry, sensitive, son, taxable, transfer, Triangle, unchanged, vesting
Filing tables
Filing exhibits
Mylan similar filings
Filing view
External links
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements Nos. 333-35887, 333-42182, 333-43081, 333-65327, 333-65329, 333-98811, 333-111076 and 333-111077 of Mylan Laboratories Inc. on Form S-8 of our report dated May 18, 2004, which report expresses an unqualified opinion and includes an explanatory paragraph relating to Mylan Laboratories Inc.’s change in method of accounting for goodwill in fiscal 2003, appearing in this Annual Report on Form 10-K of Mylan Laboratories Inc. for the year ended March 31, 2004.
/s/ Deloitte & Touche LLP
DELOITTE & TOUCHE LLP
Pittsburgh, Pennsylvania
June 11, 2004
78